IFIT3 and systemic sclerosis: Furthermore, while the primary focus of this study is on the involvement of the IFIT3/TBK1 signalling pathway in activating pDCs, it is crucial not to overlook the role of other immune and non‐immune cells in SSc, along with their respective signalling pathways.